Navigation Links
Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research
Date:10/30/2008

er to humans and the environment than traditional quantum dots that are mostly made of materials containing cadmium or lead.

Komen's Upstate South Carolina affiliate contributed $25,000 to the $180,000 grant with its local fundraising efforts. Sun has received $550,000 in National Institutes of Health support to fund research on carbon dots.


'/>"/>

Contact: Ya-Ping Sun
syaping@clemson.edu
864-656-5026
Clemson University
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. PRA International Adds Dr. Susan Stansfield as Executive Vice President
2. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
3. Arthur M. Blank Family Foundation Names Susan Bertonaschi Program Officer, Better Beginnings
4. Forbes Honors Susan G. Komen for the Cure Founder as Trailblazer
5. Celebrities Pledge to Wear Pink, End Breast Cancer Forever With Susan G. Komen for the Cure
6. PNY Technologies and Susan G. Komen for the Cure Partner to Raise Awareness of Breast Cancer
7. Susan G. Komen for the Cure Partners With the Original Butter Bell(R) Crock Developer
8. Susan G. Komen for the Cures Phoenix Affiliate, State Officials, Survivors and Advocates Call for Action on Breast Cancer
9. Susan G. Komen for the Cure Launches Unprecedented Global Expansion Program in 10 Countries
10. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3